251 related articles for article (PubMed ID: 17662007)
21. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
Bennet R; Lindgren V; Zweygberg Wirgart B
Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
[TBL] [Abstract][Full Text] [Related]
22. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
23. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.
Djukic M; Schmidt-Samoa C; Lange P; Spreer A; Neubieser K; Eiffert H; Nau R; Schmidt H
J Neurol; 2012 Apr; 259(4):630-6. PubMed ID: 21898139
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
25. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
Bednárová J; Stourac P; Adam P
Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
[TBL] [Abstract][Full Text] [Related]
26. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
Pfister HW; Rupprecht TA
Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
[TBL] [Abstract][Full Text] [Related]
27. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
28. Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
van Gorkom T; Voet W; van Arkel GHJ; Heron M; Hoeve-Bakker BJA; Notermans DW; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Jun; 10(3):e0006122. PubMed ID: 35404103
[TBL] [Abstract][Full Text] [Related]
29. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.
van Burgel ND; Brandenburg A; Gerritsen HJ; Kroes AC; van Dam AP
Clin Microbiol Infect; 2011 Oct; 17(10):1495-500. PubMed ID: 21375653
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
Tjernberg I; Johansson M; Henningsson AJ
Clin Chem Lab Med; 2019 Nov; 57(12):2008-2018. PubMed ID: 31199760
[TBL] [Abstract][Full Text] [Related]
31. Detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid samples following pre-enrichment culture.
Leth TA; Nymark A; Knudtzen FC; Larsen SL; Skov MN; Jensen TG; Bek-Thomsen M; Jensen HB; Hovius JW; Skarphédinsson S; Møller JK; Andersen NS
Ticks Tick Borne Dis; 2023 May; 14(3):102138. PubMed ID: 36746091
[TBL] [Abstract][Full Text] [Related]
32. Lyme neuroborreliosis and dementia.
Blanc F; Philippi N; Cretin B; Kleitz C; Berly L; Jung B; Kremer S; Namer IJ; Sellal F; Jaulhac B; de Seze J
J Alzheimers Dis; 2014; 41(4):1087-93. PubMed ID: 24762944
[TBL] [Abstract][Full Text] [Related]
33. Sublime diagnosis of Lyme neuroborreliosis.
Segal BM; Logigian EL
Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
[No Abstract] [Full Text] [Related]
34. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.
Henningsson AJ; Christiansson M; Tjernberg I; Löfgren S; Matussek A
Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):797-803. PubMed ID: 24263552
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
36. [Examination of intrathecal immunological response to Borrelia burgdorferi antigens in patients with suspected neuroborreliosis--a preliminary communication].
Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Grygorczuk S; Moniuszko A
Przegl Epidemiol; 2008; 62 Suppl 1():152-7. PubMed ID: 22320050
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis.
Ogrinc K; Lotric-Furlan S; Maraspin V; Cimperman J; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):535-8. PubMed ID: 12422597
[TBL] [Abstract][Full Text] [Related]
38. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
39. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms.
Tveitnes D; Øymar K; Natås O
Scand J Infect Dis; 2009; 41(5):355-62. PubMed ID: 19253089
[TBL] [Abstract][Full Text] [Related]
40. Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis.
Pietikäinen A; Glader O; Kortela E; Kanerva M; Oksi J; Hytönen J
Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115782. PubMed ID: 35970019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
